Company intelligence / Profile preview
Shenzhen Kangzhe Vision
- Ownership
- Private
- Employees
- ~5000
- Development stage
- Other
Overview
Kangzhe Pharmaceutical (CMS) is a leading China-based pharmaceutical company focused on the development, marketing, and promotion of innovative drugs. The company operates through specialized business units, including Kangzhe Vision, which focuses on ophthalmology, and Kangzhe Dermatology. CMS has built a robust pipeline through a combination of in-house R&D and strategic global licensing, targeting high-growth therapeutic areas such as ophthalmology, dermatology, and gastroenterology. With a strong commercialization network across China, the company successfully bridges the gap between global innovation and the Chinese healthcare market.
- Therapeutic areas
- DermatologyOphthalmology
- Modalities
- Small moleculeMonoclonal antibodyBiologic
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Shenzhen Kangzhe Vision.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenzhen Kangzhe Vision.